A case-control study of serious autoimmune adverse events following hepatitis B immunization

References

• Centers for disease control and prevention. Protection against viral hepatitis. Recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep 1990; 39: 1–26
   Google Scholar
• Centers for disease control and prevention. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood vaccination. Recommendations of the immunization practices advisory committee (ACIP). MMWR Recomm Rep 1991; 40: 1–25
   Google Scholar
• Centers for disease control and prevention. Hepatitis Surveillance report No. 51. US Department of Health and Human Services, Public Health Service, Atlanta 1987
   Google Scholar
• Centers for Disease Control and Prevention. Hepatitis Surveillance report No. 52. US Department of Health and Human Services, Public Health Service, Atlanta 1987
   Google Scholar
• Emini EA, Ellis RW, Miller WJ, McAleer WJ, Scolnick EM, Gerety RJ. Production and immunological analysis of recombinant hepatitis B vaccine. J Infect 1986; 13(Suppl. A)3–9
   PubMed Web of Science ®Google Scholar
• Stephenne J. Development and production aspects of a recombinant yeast-derived hepatitis B vaccine. Vaccine 1990; 8(Suppl.)S69–S73
   Google Scholar
• Grotto I, Mandel Y, Ephros M, Ashkenazi I, Shemer J. Major adverse reactions to yeast-derived hepatitis B vaccines—a review. Vaccine 1998; 16: 329–334
   PubMed Web of Science ®Google Scholar
• Geier MR, Geier DA, Zahalsky AC. A review of hepatitis B vaccination. Expert Opin Drug Saf 2003; 2: 113–122
   PubMedGoogle Scholar
• Geier MR, Geier DA. A case-series of adverse events, positive re-challenge of symptoms, and events in identical twins following hepatitis B vaccination: Analysis of the vaccine adverse event reporting system (VAERS) database and literature review. Clin Exp Rhuematol 2004; 22: 749–755
   PubMed Web of Science ®Google Scholar
• Maillefert JF, Sibilia J, Toussirot E, Vignon E, Eschard JP, Lorcerie B, Juvin R, Parchin-Geneste N, Piroth C, Wendling D, Kuntz JL, Tavernier C, Gaudin P. Rheumatic disorders developed after hepatitis B vaccination. Rheumatology 1999; 38: 978–983
   PubMed Web of Science ®Google Scholar
• Han SH. Extrahepatic manifestations of chronic hepatitis B. Clin Liver Dis 2004; 8: 403–418
   PubMedGoogle Scholar
• Singleton JA, Lloyd JC, Mootrey GT, Salive ME, Chen RT. An overview of the vaccine adverse event reporting system (VAERS) as a surveillance system. VAERS Working Group. Vaccine 1999; 17: 2908–2917
   PubMed Web of Science ®Google Scholar
• Hill AB. The environment and disease: Association or causation. Proc R Soc Med 1965; 58: 295–300
   PubMed Web of Science ®Google Scholar
• Haber P, Chen RT, Zanardi LR, Mootrey GT, English R, Braun MM. VAERS working group. An analysis of rotavirus vaccine reports to the vaccine adverse event reporting system: More than intussusception alone?. Pediatrics 2004; 113: e353–e359
   Web of Science ®Google Scholar
• Fine PE, Chen RT. Confounding in studies of adverse reactions to vaccines. Am J Epidemiol 1992; 136: 121–135
   PubMed Web of Science ®Google Scholar
• Cesur S, Akin K, Albayrak F, Birengel S, Kurt H, Balik I. Prevalence of extrahepatic illnesses in patients with chronic hepatitis B and hepatitis C: Retrospective study of 435 patients. Mikrobiyol Bul 2003; 37: 187–193
   PubMedGoogle Scholar
• Pennesi M, Torre G, Del Santo M, Sonzogni A. Glomerulonephritis after recombinant hepatitis B vaccine. Pediatr Infect Dis 2002; 21: 172–173
   Google Scholar
• Poirriez J. A preliminary experiment of absorption of antinuclear antibodies by the hepatitis B vaccine components, in a case of neurolupus. Vaccine 2004; 22: 3166–3168
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Aharon-Maor A, Sherer Y. Vaccination as an additional player in the mosaic of autoimmunity. Clin Exp Rheumatol 2000; 18: 181–184
   PubMed Web of Science ®Google Scholar
• Shoenfeld Y, Aron-Maor A. Vaccination and autoimmunity-‘vaccinosis’: A dangerous liaison?. J Autoimmun 2000; 14: 1–10
   PubMed Web of Science ®Google Scholar
• Ravel G, Christ M, Horand F, Descotes J. Autoimmunity, environmental exposure and vaccination: Is there a link?. Toxicology 2004; 196: 211–216
   PubMed Web of Science ®Google Scholar
• Touze E, Gout O, Verdier-Taillefer MH, Lyon-Caen O, Alperovitch A. Premier episode de demyelinisation du système nerveux central et vaccination contre l'hépatite B: Etude cas-témoins pilote. Rev Neurol 2000; 156: 242–246
   PubMed Web of Science ®Google Scholar
• Touze E, Fourrier A, Rue-Fenouche C, Ronde-Oustau V, Jeantaud I, Begaud B, Alperovitch A. Hepatitis B vaccination and first central nervous system demyelinating event: A case-control study. Neuroepidemiology 2002; 21: 180–186
   PubMed Web of Science ®Google Scholar
• Sturkenboom MCJM. Vaccinations Demyelination, and multiple sclerosis study (VDAMS). A population-based study in the UK. Pharmacoepidemiol Drug Saf 1999; 8(Suppl. 2)S170–S171
   Google Scholar
• DeStefano F, Verstraeten T, Jackson LA, Okoro CA, Benson P, Black SB, Shinefield HR, Mullooly JP, Likosky W, Chen RT. Vaccine safety datalink research group, national immunization program, centers for disease control and prevention. Vaccinations and risk of central nervous system demyelinating diseases in adults. Arch Neurol 2003; 60: 504–509
   PubMedGoogle Scholar
• Ascherio A, Zhang SM, Hernan MA, Olek MJ, Coplan PM, Brodovicz K, Walker AM. Hepatitis B vaccination and the risk of multiple sclerosis. N Engl J Med 2001; 344: 327–332
   PubMed Web of Science ®Google Scholar
• Zipp F, Weil JG, Einhäupl KM. No increase in demyelinating diseases after hepatitis B vaccination. Nat Med 1999; 5: 964–965
   PubMed Web of Science ®Google Scholar
• Sadovnick AD, Scheifele DW. School-based hepatitis B vaccination programme and adolescent multiple sclerosis. Lancet 2000; 355: 549–550
   PubMed Web of Science ®Google Scholar
• Hernan MA, Jick SS, Olek MJ, Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis: A prospective study. Neurology 2004; 63: 838–842
   PubMed Web of Science ®Google Scholar
• Girard M. Autoimmune hazards of hepatitis B vaccine. Autoimmun Rev 2005; 4: 96–100
   PubMed Web of Science ®Google Scholar
• De Becker P, McGregor N, De Meirleir K. Possible triggers and mode of onset of chronic fatigue syndrome. J Chronic Fatigue Synd 2002; 10: 3–18
   Google Scholar